Universitätsklinikum Ulm

Working conditions and mental health of migrants and refugees in Europe considering cultural origin– a systematic review (2024) Herold R, Lieb M, Borho A, Voss A, Unverzagt S, Morawa E, Rothermund E, Erim Y Journal article Impairment of α-tubulin and F-actin interactions of GJB3 induces aneuploidy in urothelial cells and promotes bladder cancer cell invasion (2024) Liu J, Wang X, Jiang W, Azoitei A, Eiseler T, Eckstein M, Hartmann A, et al. Journal article Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer (2024) Fasching P, Hu C, Hart SN, Rübner M, Polley EC, Gnanaolivu RD, Hartkopf AD, et al. Journal article Mentally strained: pathways into and through the working world Psychisch belastet: Wege in und durch die Arbeitswelt (2024) Angerer P, Erim Y, Kröger C, Kuhn J, Rothermund E Journal article Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry Real-World-Daten des deutschen PRAEGNANT-Registers zu Therapieabbr chen der ersten 3 Therapielinien bei Patientinnen mit fortgeschrittenem Brustkrebs (2024) Hartkopf AD, Walter CB, Kolberg HC, Hadji P, Tesch H, Fasching P, Ettl J, et al. Journal article CDK4/6 Inhibition - Therapy Sequences and the Quest to Find the Best Biomarkers - An Overview of Current Programs CDK4/6-Inhibition: Sequenztherapien und die Suche nach den besten Biomarkern ein berblick ber die aktuellen Programme (2024) Schneeweiss A, Brucker SY, Hübner H, Volmer LL, Hack C, Seitz K, Rübner M, et al. Journal article, Review article Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE) (2024) Meyer-Wilmes P, Huober J, Untch M, Blohmer JU, Janni W, Denkert C, Klare P, et al. Journal article 12-Month Trajectories of Health-Related Quality of Life Following Hospitalization in German Cancer Centers—A Secondary Data Analysis (2024) Eichler M, Hönig K, Bergelt C, Faller H, Maatouk I, Hornemann B, Stein B, et al. Journal article Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer (2024) Gaß P, Thiel FC, Häberle L, Ackermann S, Theuser AK, Hummel N, Boehm S, et al. Journal article Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia (2024) Burmeister T, Ströh AS, Kehden B, Trautmann H, Meyer C, Marschalek R, Larghero P, et al. Journal article, Letter